These medications are semaglutide (with brand names such as Wegovy and Ozempic) and tirzepatide (Monjaro) originally developed for managing type 2 diabetes, now recognized for their significant benefits in weight loss and overall health improvement
If youre struggling with: Weight gain despite diet and exercise Constant hunger or cravings Slow metabolism or insulin resistance GLP-1 medications help regulate appetite, reduce cravings, and support consistent, sustainable weight loss
Experimental Study Period STUDY PERIOD 812 weeks WASHOUT PERIOD 48 weeks ADJUSTMENT NOTES Not required RESEARCH CONTEXT Maintains metabolic sensitivity and optimises long-term results These tables show common research dosages
Studies have shown that B-12 positively affects the brain, helping reduce stress and improve cognitive functioning
While some of these benefits come indirectly via weight loss, GLP-1s seem to also directly impact different organs by reducing inflammation or via other biological pathways
This is simply because Ozempic drug trials focused on how it impacted blood sugar (like metformin does), while Wegovy drug trials focused on how it impacted weight
